Individual Housing Loans: Rationalization of Risk-Weights and LTV Ratios

Similar documents
SKS Microfinance. CMP: INR478 TP: INR589 (+23%) Buy Clouds of uncertainty cleared. RBI to be the sole regulator of the MFI sector

S4A An ammunition to cut the debt trap

ECOSCOPE. Real GDP growth eases on lower net indirect taxes. The Economy Observer. Real GVA growth exactly as expected

Making RBI captain of the ship. NPA resolution Is it enough?

CMP: INR53 TP: INR70 (+33%) Buy

No significant jump in retail electronic payments post demonetization

CMP: INR374 TP: INR500 (+34%) Buy Fuelled with capital

REPORT THREADBARE. New accounting standards from FY The ART of annual report analysis

CMP: INR602 TP: INR758(+26%) Buy Gradual re-rating to continue

CMP: INR501 TP: INR716(+43%) Buy Significant benefits from demonetization

City Union Bank BUY. 24 February 2016 INR82

Muthoot Finance. CMP: INR215 TP: INR266 (+24%) Buy

No major improvement in value proposition expected

Muthoot Finance. CMP: INR181 TP: INR233 (29%) Buy

Can Fin Homes BUY. 23 September 2015 INR821

Rural Electrification

Sohail Halai Alpesh Mehta

Dr Urjit Patel to maintain continuity of monetary policy stance

Oriental Bank of Commerce

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

CMP: INR335 TP: INR409 (+22%) Buy

ECOSCOPE. 3QFY16 CAD/GDP corrects to 1.3% The Economy Observer. Balance of Payments. See surplus in 4Q and to remain low in FY17; INR to correct still

LIC Housing Finance. CMP: INR520 TP: INR627 (+21%) Buy

Decent performance by the sector in a tough quarter

Hardick Bora

CMP: INR75 TP: INR68 (-9%) Neutral Continued clean-up to hurt profitability

CMP: INR558 TP: INR761 (+36%) Buy Falling yields favor LICHF due to liability mix

CMP: INR826 TP: INR810 (-2%) Neutral

Urban demand revives; Akzo gaining market share

Andhra Bank. CMP: INR77 TP: INR120 (+56%) Buy. Strong core performance; Positive asset quality guidance by management

Bajaj Finance. CMP: INR6,381 TP: INR7,194 (+13%) Buy

South Indian Bank. CMP: INR23 TP: INR30 (+35%) Buy. Weak asset quality continues to impact profitability; valuations attractive

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Niket Shah

CMP: INR473 TP: INR545(+15%) Buy Mega merger on the anvil

Bajaj Finance. CMP: INR5,306 TP: INR5,923 (+11%) Buy

Financial integrity intact; FDA resolution the key

Canara Bank. CMP: INR419 TP: INR525 Buy

IDBI Bank. CMP: INR106 TP: INR121 Neutral

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive

Stress test: Weak capital servicing ratios to drive pricing discipline

Expect capacity-led rerating; maintain Buy

Proposed quality order can contain imports. These measures can at best protect downside risk to estimates. 16 December

SHRIRAM TRANSPORT FINANCE COMPANY LTD

Sanjay Jain Pavas Pethia

IDFC Bank. CMP: INR63 TP: INR68 (8%) Neutral

Oil & Gas. India FY16 POL consumption growth at 8 year high of 11% Petroleum, oil and lubricants (POL) consumption grows at double digits

IndusInd Bank. CMP: INR345 TP: INR419 Buy

CMP: INR2,623 TP: INR2,875 (+10%) Neutral

CMP: INR865 TP: INR1,015 (+17%) Buy Building blocks for strong growth

Titan Industries. CMP: INR222 TP: INR220 Neutral

IDFC Bank. CMP: INR61 TP: INR62 (2%) Neutral Focus on inorganic opportunities; stressed assets stable

Punjab National Bank. CMP: INR716 TP: INR950 Buy

CMP: INR475 TP: INR609 (+28%) Buy

CMP: INR949 TP: INR1,140 (+20%) Buy

CMP: INR350 TP: INR375 Downgrade to Neutral

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

CMP: INR415 TP: INR 471 BUY

Mr Aditya Puri MD and CEO. HDFC Bank. It s all about being digital. Key takeaways from CEO Track

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block

CMP: INR1,054 TP: INR1,276 (+21%) Buy

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Century Plyboards (I) Limited

CMP: INR2,013 TP: INR2,384 (+18%) DBEL to be merged with OCL India

Punjab National Bank. CMP: INR133 TP: INR175 (+32%) Buy. PAT below est. led by higher write-offs; Growth remains moderate

KNR CONSTRUCTIONS LTD

CMP: INR170 TP: INR240 (+41%) Buy Well capitalized for growth

RJio sturdy as Battle Royale gets exciting

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

Bank of India. CMP: INR80 TP: INR85 (+6%) Neutral

Kotak Mahindra Bank. CMP: INR689 TP: INR685 (-1%) Neutral

Market share recovery, price hike, content leverage to drive growth

Piyush Goyal, MoS (IC) for Power, Coal, RE & Mining

Castrol India. CMP: INR407 TP: INR474 (+16%) Neutral

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Godrej Consumer Products

CMP: INR1,543 TP: INR1,800 (+17%) Buy

CMP: INR9,853 TP: INR10,712 (+9%) Buy

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

CMP: INR158 TP: INR199 (+26%) Buy NTPC FY16 annual report analysis

Reliance Infrastructure CMP: INR528

ULTRAMARINE & PIGMENTS LTD

CMP: INR859 TP: INR810 (-6%) Neutral

Siddharth Bothra

BGR Energy. CMP: INR266 TP: INR230 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral

Significant value unlocking on the cards

Idea Cellular. CMP: INR159 TP: INR200 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Canara Bank. CMP: INR464 TP: INR645 Buy

NTPC CMP: INR169 TP: INR191 Buy

CMP: INR830 TP: INR1,040(+25%) Buy Driving value through simplification

Kotak Mahindra Bank. CMP: INR761 TP: INR866 (+14%) Buy. In-line, healthy lending business performance; stable asset quality

Jinesh Gandhi Chirag Jain

To voluntarily stop supplies to US

May-14. Jan-14. Jun-14. Dec-13. Aug-13. Sep-13. Nov-13. Feb-14. Oct-13. Mar-14. Apr-14. Will recent momentum in North-Central India sustain?

Jinesh Gandhi Sandipan Pal

ABB India to remain a key sourcing hub

Transcription:

8 October 2015 Sector Update Financials Individual Housing Loans: Rationalization of Risk-Weights and LTV Ratios Significant capital release for HFCs; Limited benefits for banks Event: RBI reduces risk weights on housing loans of up to INR7.5m based on LTV slabs. It has also increased the minimum ticket size on the lowest risk weight to INR3m from INR2m earlier. Post modifications, lowest risk weight on individual housing loans reduce to 35% from 50% earlier (Please refer to exhibit #1) Our view: Reduction in risk weights would be mild positive for banks however, will lead to significant capital release for HFCs (once NHB also implements similar guidelines). Based on back of the envelope calculations, banks which have higher proportion of home loans could see ~15-20bp capital release. However, in case of large HFCs, capital release could be 50-250bp; In case of HFCs which are engaged in affordable housing segment, capital release could be very significant up to 300bp (exhibit #4). Important things to be considered a) While capital release can be significant for HFCs, balance sheet leverage is more important to maintain credit rating (most important to manage spreads), b) in our view, high share of loans for below INR7.5m can be in the bracket of >75% LTV at the time of origination where risk weights have not been altered from 50%. Opportunity remains big - Push to affordable housing to increase: Lower risk weights, cheap source of funding (infra bonds) and increasing presence of private banks in rural/semi urban locations is likely to give a significant push to affordable housing lending. Despite thin spreads, banks typically approach housing loans as customer acquisition strategy for long term relationships (to earn higher revenues via cross sell in future); thus, growth is likely to accelerate further. Minimum ticket size increased; new slabs introduced for loans up to INR7.5mn based on LTVs Exhibit 1: Existing NHB norms on risk weights for loan amount and LTV ratios Revised Guideline Category of loan LTV ratio (%) Risk Weight (%) Up to INR 3mn 80 35 > 80 and 90 50 Above INR 3mn and up to INR 7.5mn 75 35 > 75 and 80 50 Above INR 7.5mn 75 75 Old Guideline Up to INR 2mn 90 50 Above INR 2mn and up to INR 7.5mn 80 50 Above INR 7.5mn 75 75 Source: RBI, MOSL Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 3982 5415 Sunesh Khanna (Sunesh.Khanna@MotilalOswal.com); +91 22 3982 5521 Investors are advised to refer through disclosures made at the end of the Research Report. 2 Motilal June 2014 Oswal research is available on www.motilaloswal.com/institutional-equities, Bloomberg, Thomson Reuters, Factset and S&P Capital. 1

Financials Sector Update Large banks could see 15-20bp capital release Average risk weight on the housing loan portfolio will decline by >10% (refer exhibit #3). Housing loans as a percentage of total loan book is ~12% for banking system. For every 10% weighted average reduction in housing loans risk weights, we expect ~15bp improvement in CET1. For the large banks with the high share of home loan portfolio could see CET1 improve by 15-20bp Exhibit 2: ICICIBC, AXSB and SBIN have relatively higher proportion of home loans Home loans account for 30%+ of ICICIBC s domestic loan book 23 31 19 23 % of Global loans % of Domestic loans 15 12 11 5 8 7 7 5 6 5 6 ICICIBC AXSB SBIN Industry BOB HDFCB PNB CBK Source: MOSL, Company Exhibit 3: AXSB, ICICIBC and SBIN to be the biggest beneficiary with ~15-20bp improvement in CET1 ratio (%) INR b % of home loans* Old Risk Weights New Risk Weights RWA (INR b) INR b Approx. % of Bank Total Home Impact loans < INR > INR < INR > INR < INR > INR Current Blended Blended Current Revised Loans Loans 7.5mn 7.5mn 7.5mn 7.5mn 7.5mn 7.5mn CET1 (bps) AXSB 2,811 537 19 70% 30% 50% 75% 58% 35% 75% 47% 3,620 3,564 440 19 ICICIBC 3,997 938 23 60% 40% 50% 75% 60% 35% 75% 51% 5,692 5,608 698 18 SBIN 13,137 1,637 12 85% 15% 50% 75% 54% 35% 75% 41% 12,447 12,238 1194 16 Note: * assumption; Source: MOSL, Company HFCs to be the biggest beneficiaries Expect NHB to follow suit We expect NHB to follow suit in order to keep the level playing field for HFCs. For HFCs individual housing loans comprises 70-95% of the total portfolio thus, HFCs are likely to be biggest beneficiaries. Theoretically, while the leverage can increase; it is generally capped at 10-12x in order to keep cost of funds lower (as rating agencies are not comfortable beyond these levels). In case of large HFCs, capital release could be 50-250bp whereas, HFCs engaged in affordable housing segment could see up to 300bp release in capital. Exhibit 4: LICHF, DEWH, GRHF and REPCO likely beneficiaries among HFCs, once NHB revises the norms INR b (%) Old Risk Weights New Risk Weights (%) Approx. Company Total Home < INR > INR < INR > INR < INR > INR Current Revised Impact Blended Blended Loans Loans 7.5mn* 7.5mn* 7.5mn 7.5mn 7.5mn 7.5mn CET1 CET 1 (bp) HDFC 2,312 1,619 60% 40% 50% 75% 60% 35% 75% 51% 14.9 16.0 110 LICHF 1,104 1,077 70% 30% 50% 75% 58% 35% 75% 47% 12.1 14.3 221 DHFL 538 398 80% 20% 50% 75% 55% 35% 75% 43% 12.1 14.0 186 IHFL 479 249 50% 50% 50% 75% 63% 35% 75% 55% 15.0 15.8 77 REPCO 63 51 70% 30% 50% 75% 58% 35% 75% 47% 20.0 22.9 297 GRHF 93 84 75% 25% 50% 75% 56% 35% 75% 45% 14.1 17.0 284 *These numbers are based on our assumption. However, the actual figures may vary. Source: MOSL, Company 8 October 2015 2

Financials Sector Update Exhibit 5: Financials: Valuation metrics 66 Rating CMP Mcap EPS (INR) P/E (x) BV (INR) P/BV (x) RoA (%) RoE (%) (INR) (USDb) FY16 FY17 FY16 FY17 FY16 FY17 FY16 FY17 FY16 FY17 FY16 FY17 ICICIBC* Buy 278 24.5 21.5 25.8 10.0 7.9 131 150 1.63 1.37 1.54 1.58 14.8 15.7 HDFCB Buy 1,084 41.2 49.1 59.2 22.1 18.3 285 330 3.80 3.28 1.89 1.86 18.4 19.2 AXSB Buy 491 17.6 36.5 43.3 13.4 11.4 218 254 2.25 1.94 1.78 1.82 18.0 18.3 KMB* Neutral 654 18.1 18.2 25.3 36.0 25.9 182 207 3.59 3.16 1.01 1.32 13.9 14.5 YES Buy 729 4.6 59.9 74.5 12.2 9.8 327 387 2.23 1.88 1.68 1.73 19.7 20.9 IIB Buy 946 8.4 40.2 50.2 23.5 18.9 294 338 3.21 2.80 1.98 2.03 17.2 15.9 DCBB Buy 140 0.6 6.9 9.4 20.4 15.0 62 71 2.27 1.97 1.07 1.15 11.8 14.1 FB Buy 65 1.7 5.4 6.7 12.0 9.6 49 54 1.31 1.19 1.02 1.06 11.4 13.0 JKBK Neutral 91 0.7 14.1 17.3 6.4 5.2 136 150 0.66 0.61 0.85 0.92 10.7 12.1 SIB Buy 23 0.5 2.2 3.1 10.2 7.3 28 31 0.80 0.73 0.47 0.59 8.2 10.5 Private Aggregate 117.8 17.9 14.8 2.70 2.37 SBIN (cons)* Buy 243 27.9 25.6 31.7 9.0 7.3 229 255 1.01 0.90 0.70 0.77 11.7 13.1 PNB Buy 139 3.9 19.6 26.8 7.1 5.2 220 244 0.63 0.57 0.57 0.70 9.3 11.6 BOI Neutral 146 1.5 19.4 27.1 7.5 5.4 410 432 0.36 0.34 0.20 0.25 4.8 6.4 BOB Buy 186 1.2 20.3 25.1 9.1 7.4 182 201 1.02 0.92 0.61 0.68 11.7 13.1 CBK Buy 298 2.3 43.8 59.7 6.8 5.0 573 619 0.52 0.48 0.39 0.48 8.1 10.0 UNBK Buy 185 1.8 35.7 46.6 5.2 4.0 317 356 0.58 0.52 0.56 0.65 11.8 13.9 OBC Buy 145 0.7 46.3 63.8 3.1 2.3 474 523 0.31 0.28 0.57 0.69 10.1 12.8 INBK Buy 141 1.0 21.1 30.6 6.7 4.6 278 301 0.51 0.47 0.50 0.65 7.8 10.6 CRPBK Neutral 45 0.1 16.5 21.9 2.7 2.1 141 158 0.32 0.29 0.54 0.64 12.3 14.7 ANDB Buy 69 0.6 17.8 22.8 3.9 3.0 180 196 0.38 0.35 0.55 0.62 10.3 12.2 IDBI Neutral 79 1.9 14.4 19.7 5.5 4.0 157 173 0.50 0.46 0.58 0.69 9.5 11.9 DBNK Neutral 42 0.4 8.8 12.5 4.8 3.4 126 136 0.33 0.31 0.36 0.44 7.2 9.6 Public Aggregate 43.4 7.8 6.0 0.71 0.65 HDFC* Buy 1,278 30.5 38 44 21.9 17.2 167 192 5.00 3.93 2.60 2.60 23.6 24.4 LICHF Buy 475 3.6 34 42 14.0 11.2 182 216 2.61 2.20 1.49 1.54 20.2 21.3 DEWH Buy 222 1.0 26 33 8.4 6.7 179 204 1.24 1.09 1.27 1.29 15.6 17.3 IHFL Buy 755 4.9 57 72 13.2 10.5 275 305 2.74 2.48 4.08 4.19 26.5 24.7 GRHF Buy 262 1.4 7 9 37.9 30.1 24 29 11.05 9.15 2.23 2.09 29.4 29.0 REPCO Buy 728 0.7 24 34 29.8 21.3 152 182 4.79 4.00 2.20 2.32 17.3 20.4 IDFC Buy 63 1.5 10 12 6.4 5.4 107 116 0.32 0.28 1.75 1.83 8.8 9.8 RECL Buy 268 4.0 63 76 4.2 3.5 302 360 0.89 0.75 3.22 3.23 22.9 22.9 POWF Buy 236 4.7 54 60 4.4 3.9 285 329 0.83 0.72 3.07 3.03 20.4 19.7 SHTF Buy 950 3.3 62 73 15.2 13.1 458 515 2.07 1.84 2.10 2.28 14.1 14.9 MMFS Buy 235 2.0 12 15 19.6 15.5 109 120 2.16 1.96 1.92 2.20 11.5 13.2 BAF Buy 5,053 4.1 222 261 22.7 19.4 1,350 1,568 3.74 3.22 3.13 2.84 19.8 17.9 MUTH Buy 180 5.4 20 24 11.9 9.9 141 156 1.67 1.51 2.75 2.83 14.7 16.0 NBFC Aggregate 61.7 15.3 13.1 2.67 2.34 *Multiples adj. for value of key ventures/investments; For ICICI Bank and HDFC Ltd BV is adjusted for investments in subsidiaries 8 October 2015 3

Financials Sector Update N O T E S 8 October 2015 4

STRATEGIES REPORT GALLERY COMPANIES SECTOR UPDATES

Disclosures This document has been prepared by Motilal Oswal Securities Limited (hereinafter referred to as Most) to provide information about the company(ies) and/sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This report is for personal information of the selected recipient/s and does not construe to be any investment, legal or taxation advice Financials to you. This research Sector report Update does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business relationships with a some companies covered by our Research Department. Our research professionals may provide input into our investment banking and other business selection processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may educate investors on investments in such business. The research professionals responsible for the preparation of this document may interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting information. Our research professionals are paid on the profitability of MOSt which may include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing among other things, may give rise to real or potential conflicts of interest. MOSt and its affiliated company(ies), their directors and employees and their relatives may; (a) from time to time, have a long or short position in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s) are completely independent of the views of the affiliates of MOSt even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report Reports based on technical and derivative analysis center on studying charts company's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamental analysis. In addition MOST has different business segments / Divisions with independent research separated by Chinese walls catering to different set of customers having various objectives, risk profiles, investment horizon, etc, and therefore may at times have different contrary views on stocks sectors and markets. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt s interpretation of the data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. Most and it s associates may have managed or co-managed public offering of securities, may have received compensation for investment banking or merchant banking or brokerage services, may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Most and it s associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. Subject Company may have been a client of Most or its associates during twelve months preceding the date of distribution of the research report MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise of over 1 % at the end of the month immediately preceding the date of publication of the research in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Motilal Oswal Securities Limited is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014. SEBI Reg. No. INH000000412 There are no material disciplinary action that been taken by any regulatory authority impacting equity research analysis activities Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues Disclosure of Interest Statement Companies where there is interest Analyst ownership of the stock No Served as an officer, director or employee No A graph of daily closing prices of securities is available at www.nseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Kadambari Balachandran Email : kadambari.balachandran@motilaloswal.com Contact : (+65) 68189233 / 65249115 Office Address : 21 (Suite 31),16 Collyer Quay,Singapore 04931 Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 8 October 2015 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com 6